922P - Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma
| Autor: | Loriot, Y., Sternberg, C.N., Castellano Gauna, D., Dumez, H., Huddart, R., Vianna, K.M., Alonso Gordoa, T., Skoneczna, I.A., Fay, A., Sacco, C.S.P., Nole, F., Massari, F., Brasiuniene, B., Maroto, P., Oosting, S.F., Fear, S., Di Nucci, F., De Ducla, S., Choy, E. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v368-v369 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|